Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Validation of CXCL9 as a biomarker of morphoea disease state and severity through longitudinal analysis

British Journal of Dermatology(2025)10.1093/bjd/ljaf267Source: DataRank Database

Validation of CXCL9 as a biomarker of morphoea disease state and severity through longitudinal analysis is a research paper published in British Journal of Dermatology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.78)OA: greenTopics (46)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Grant Barber ORCID,Jenny Foster ORCID,Christina K. Zigler ORCID,Jack C. O’Brien ORCID,Heidi Jacobe ORCID

Live enrichment

PubMed:40663637 OpenAlex:https://openalex.org/W4412432037

National Institutes of Health

Grant: R01AR073516

National Institutes of Health

Grant: R01AR078560

Rheumatology Research Foundation

NCRR NIH HHS

Pediatric Dermatology Research Alliance

National Center for Research Resources

Medical Student Research Fellowship

Rheumatology Research Foundation

NCRR NIH HHS

Pediatric Dermatology Research Alliance

FWCI

0.78

Citation Percentile

0.7%

Citation Trend

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12626135/

publisherhttps://academic.oup.com/bjd/advance-article-pdf/doi/10.1093/bjd/ljaf267/63772046/ljaf267.pdf

publisherhttps://academic.oup.com/bjd/article-pdf/193/6/1174/63772046/ljaf267.pdf

journalhttps://doi.org/10.1093/bjd/ljaf267

Fields of Study

Systemic Sclerosis and Related DiseasesInflammatory Myopathies and DermatomyositisSkin Diseases and DiabetesHumansChemokine CXCL9MaleFemaleBiomarkersLongitudinal StudiesMiddle AgedAdultScleroderma, LocalizedSeverity of Illness IndexProspective StudiesEnzyme-Linked Immunosorbent AssayYoung AdultCase-Control StudiesAgedAdolescent

MeSH Terms

AdolescentAdultAgedEnzyme-Linked Immunosorbent AssayFemaleHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesScleroderma, LocalizedSeverity of Illness IndexBiomarkersCase-Control StudiesChemokine CXCL9Young Adult

Keywords

MorpheaMedicineBiomarkerInternal medicineCXCL9GastroenterologyProspective cohort studyChemistryBiopsyCXCL10Chemokine

Sustainable Development Goals

SDG 0: Good health and well-being